search icon
search icon
Flag Arrow Down
Română
Română
Magyar
Magyar
English
English
Français
Français
Deutsch
Deutsch
Italiano
Italiano
Español
Español
Русский
Русский
日本語
日本語
中国人
中国人

Change Language

arrow down
  • Română
    Română
  • Magyar
    Magyar
  • English
    English
  • Français
    Français
  • Deutsch
    Deutsch
  • Italiano
    Italiano
  • Español
    Español
  • Русский
    Русский
  • 日本語
    日本語
  • 中国人
    中国人
Sections
  • News
  • Exclusive
  • INSCOP Surveys
  • Podcast
  • Diaspora
  • Republic of Moldova
  • Politics
  • Economy
  • Current Affairs
  • International
  • Sport
  • Health
  • Education
  • IT&C knowledge
  • Arts & Lifestyle
  • Opinions
  • Elections 2025
  • Environment
About Us
Contact
Privacy policy
Terms and conditions
Quickly scroll through news digests and see how they are covered in different publications!
  • News
  • Exclusive
    • INSCOP Surveys
    • Podcast
    • Diaspora
    • Republic of Moldova
    • Politics
    • Economy
    • Current Affairs
    • International
    • Sport
    • Health
    • Education
    • IT&C knowledge
    • Arts & Lifestyle
    • Opinions
    • Elections 2025
    • Environment
  1. Home
  2. Health
160 new news items in the last 24 hours
3 July 11:52

Dr. Beatrice Anghel discusses modern treatment options for cervical and endometrial cancer recurrences

Eftene Ana Maria
whatsapp
facebook
linkedin
x
copy-link copy-link
main event image
Health
Foto: Shutterstock.com
In cases of recurrence of cervical or endometrial cancer, modern treatments aim to avoid mutilating surgery. These include a mix of radiotherapy, chemotherapy, immunotherapy and targeted therapies determined by a multidisciplinary oncology committee. For vaginal recurrences, interstitial brachytherapy is the main method, providing local action without affecting neighboring organs. Patients are encouraged to refer to specialized centres.

Sources

sursa imagine
Digi24
Soluții moderne pentru cancerele ginecologice recidivate

ȘTIRI PE ACELEAȘI SUBIECTE

event image
Health
A global study shows that 77% of patients observed a reduction in tumors with zongertinib, an innovative treatment for HER2 lung cancer.
app preview
Personalized news feed, AI-powered search, and notifications in a more interactive experience.
app preview app preview
treatment cancer

Editor’s Recommendations

main event image
International
2 hours ago

The Drone Wall: from phrase to reality

main event image
International
2 hours ago

The Shield of European Democracy: how the EU tries to defend the truth in the era of disinformation

app preview
Personalized news feed, AI-powered search, and notifications in a more interactive experience.
app preview
app store badge google play badge
  • News
  • Exclusive
  • INSCOP Surveys
  • Podcast
  • Diaspora
  • Republic of Moldova
  • Politics
  • Economy
  • Current Affairs
  • International
  • Sport
  • Health
  • Education
  • IT&C knowledge
  • Arts & Lifestyle
  • Opinions
  • Elections 2025
  • Environment
  • About Us
  • Contact
Privacy policy
Cookies Policy
Terms and conditions
Open source licenses
All rights reserved Strategic Media Team SRL

Technology in partnership with

anpc-sal anpc-sol